Lucid Diagnostics: Strong Buy Rating With Significant Market Potential Despite Near-Term Losses
TipRanksApr 15 05:15 ET
Lucid Diagnostics Analyst Ratings
BenzingaApr 12 04:35 ET
Buy Rating Affirmed for Lucid Diagnostics Amidst Strong EsoGuard Testing Growth and Clear Reimbursement Path
TipRanksApr 11 16:45 ET
Analysts Are Bullish on Top Healthcare Stocks: Lucid Diagnostics (LUCD), Werewolf Therapeutics (HOWL)
TipRanksApr 10 13:50 ET
Buy Rating Affirmed for PAVmed With Strategic Focus on Lucid Diagnostics and Veris Cancer Care Amid Adjusted Price Target
TipRanksMar 29 07:46 ET
Buy Rating for Lucid Diagnostics: Solid Test Volumes and Strategic Growth Initiatives Propel Market Position
TipRanksMar 28 07:07 ET
Buy Rating Affirmed for Lucid Diagnostics Amid Strong Financials and Strategic Growth Initiatives
TipRanksMar 27 14:45 ET
Buy Rating Affirmed for Lucid Diagnostics Amidst Growing Test Volume and Strategic Positioning for Medicare Reimbursement
TipRanksMar 27 05:25 ET
Lucid Diagnostics Analyst Ratings
BenzingaMar 27 05:18 ET
BTIG Sticks to Its Buy Rating for Lucid Diagnostics (LUCD)
TipRanksJan 2 09:32 ET
BTIG Keeps Their Buy Rating on Lucid Diagnostics (LUCD)
TipRanksDec 31, 2023 05:19 ET
Needham Reiterates Buy on Lucid Diagnostics Following Investor Day
InvestingDec 14, 2023 09:44 ET
Analysts Offer Insights on Healthcare Companies: Atreca (BCEL), Lucid Diagnostics (LUCD) and Vertex Pharmaceuticals (VRTX)
TipRanksNov 15, 2023 07:21 ET
Needham Maintains Buy on Lucid Diagnostics, Lowers Price Target to $2.5
BenzingaNov 14, 2023 13:43 ET
Lucid Diagnostics Analyst Ratings
BenzingaNov 14, 2023 13:42 ET
Lucid Diagnostics Analyst Ratings
BenzingaSep 26, 2023 11:44 ET
Cantor Fitzgerald Reiterates Overweight on Lucid Diagnostics, Maintains $4 Price Target
BenzingaAug 22, 2023 11:37 ET
Lucid Diagnostics Analyst Ratings
BenzingaAug 22, 2023 11:36 ET
Lucid Diagnostics Analyst Ratings
BenzingaAug 16, 2023 04:06 ET
Needham Adjusts Price Target on Lucid Diagnostics to $2.80 From $2.60, Maintains Buy Rating
MT NewswiresMay 17, 2023 07:18 ET
No Data
No Data